可调节的GAL1启动子使Erg11p过表达，从而赋予酿酒酵母对氟康唑的抗性。
Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae.
作者信息
Kontoyiannis D P, Sagar N, Hirschi K D
机构信息
Department of Internal Medicine Specialties, Section of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
出版信息
Antimicrob Agents Chemother. 1999 Nov;43(11):2798-800. doi: 10.1128/AAC.43.11.2798.
Abstract
The contribution of the dosage of target enzyme P-450 14alpha-demethylase (14alphaDM) to fluconazole resistance in both Candida albicans and Saccharomyces cerevisiae remains unclear. Here, we show that overexpression of Saccharomyces P-450 14alphaDM in S. cerevisiae, under the control of the regulatable promoter GAL1, results in azole resistance.
摘要
目标酶P-450 14α-脱甲基酶（14αDM）的剂量对白色念珠菌和酿酒酵母中氟康唑耐药性的影响仍不清楚。在此，我们表明，在可调节启动子GAL1的控制下，酿酒酵母中酿酒酵母P-450 14αDM的过表达会导致唑类耐药。
相似文献
1
Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae.
Antimicrob Agents Chemother. 1999 Nov;43(11):2798-800. doi: 10.1128/AAC.43.11.2798.
2
A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
FEMS Yeast Res. 2017 May 1;17(3). doi: 10.1093/femsyr/fox012.
3
Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem.
FEMS Microbiol Lett. 1999 Nov 15;180(2):171-5. doi: 10.1111/j.1574-6968.1999.tb08792.x.
4
Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
Antimicrob Agents Chemother. 1998 Feb;42(2):241-53. doi: 10.1128/AAC.42.2.241.
5
Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.
Microbiol Immunol. 2004;48(12):937-43. doi: 10.1111/j.1348-0421.2004.tb03623.x.
6
Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
Microbiology (Reading). 1999 Oct;145 ( Pt 10):2715-25. doi: 10.1099/00221287-145-10-2715.
7
Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02242-17. Print 2018 Mar.
8
The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity.
J Biol Chem. 1997 Feb 28;272(9):5682-8. doi: 10.1074/jbc.272.9.5682.
9
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
Microbiology (Reading). 1999 Oct;145 ( Pt 10):2701-2713. doi: 10.1099/00221287-145-10-2701.
10
Genetic analysis of azole resistance in the Darlington strain of Candida albicans.
Antimicrob Agents Chemother. 2000 Nov;44(11):2985-90. doi: 10.1128/AAC.44.11.2985-2990.2000.
引用本文的文献
1
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research.
J Fungi (Basel). 2024 May 27;10(6):382. doi: 10.3390/jof10060382.
2
What 'Omics can tell us about antifungal adaptation.
FEMS Yeast Res. 2022 Jan 11;21(8). doi: 10.1093/femsyr/foab070.
3
Synergized with to Increase the Pathogenesis and Drug Resistance in Cutaneous Abscess and Peritonitis Murine Models.
Pathogens. 2021 Aug 16;10(8):1036. doi: 10.3390/pathogens10081036.
4
Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS).
Chem Rev. 2021 May 12;121(9):5289-5335. doi: 10.1021/acs.chemrev.0c00983. Epub 2021 Apr 22.
5
Transcriptomic studies on Purpureocillium lilacinum reveal molecular mechanisms of response to fluconazole and itraconazole.
Braz J Microbiol. 2021 Jun;52(2):491-501. doi: 10.1007/s42770-021-00459-6. Epub 2021 Mar 2.
6
Optogenetic Repressors of Gene Expression in Yeasts Using Light-Controlled Nuclear Localization.
Cell Mol Bioeng. 2019 Sep 24;12(5):511-528. doi: 10.1007/s12195-019-00598-9. eCollection 2019 Oct.
7
A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts.
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01483-17. Print 2018 Jan.
8
Quaternary ammonium salt -(dodecyloxycarboxymethyl)--trimethyl ammonium chloride induced alterations in physiology.
J Biosci. 2016 Dec;41(4):601-614. doi: 10.1007/s12038-016-9644-7.
9
The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn.
Virulence. 2016 Aug 17;7(6):649-59. doi: 10.1080/21505594.2016.1188236. Epub 2016 May 24.
10
9-O-butyl-13-(4-isopropylbenzyl)berberine, KR-72, is a potent antifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene expression.
PLoS One. 2014 Oct 10;9(10):e109863. doi: 10.1371/journal.pone.0109863. eCollection 2014.
本文引用的文献
1
Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Antimicrob Agents Chemother. 1998 Nov;42(11):2932-7. doi: 10.1128/AAC.42.11.2932.
2
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
Clin Microbiol Rev. 1998 Apr;11(2):382-402. doi: 10.1128/CMR.11.2.382.
3
Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
Antimicrob Agents Chemother. 1998 Feb;42(2):241-53. doi: 10.1128/AAC.42.2.241.
4
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7. doi: 10.1128/AAC.41.7.1482.
5
Molecular mechanisms of azole resistance in fungi.
FEMS Microbiol Lett. 1997 Apr 15;149(2):141-9. doi: 10.1111/j.1574-6968.1997.tb10321.x.
6
The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity.
J Biol Chem. 1997 Feb 28;272(9):5682-8. doi: 10.1074/jbc.272.9.5682.
7
Molecular genetic analysis of azole antifungal mode of action.
Biochem Soc Trans. 1993 Nov;21(4):1034-8. doi: 10.1042/bst0211034.
8
Isolation of the gene for cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.
Gene. 1988 Sep 7;68(2):229-37. doi: 10.1016/0378-1119(88)90025-x.
9
Construction of a GAL1-regulated yeast cDNA expression library and its application to the identification of genes whose overexpression causes lethality in yeast.
Genetics. 1992 Nov;132(3):665-73. doi: 10.1093/genetics/132.3.665.
Zotero 插件